Daniel J. Royston
Oxford, ENG OX39DS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.
Journal: Science translational medicine
Published: July 01, 2026
Accuracy of Diagnosis in Myeloproliferative Neoplasms With Splanchnic Vein Thrombosis (MPN-SVT).
Journal: American journal of hematology
Published: March 01, 2026
Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.
Journal: HemaSphere
Published: December 05, 2025
Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.
Journal: Blood advances
Published: August 01, 2025
A reconfigurable arbitrary retarder array as complex structured matter.
Journal: Nature communications
Published: February 09, 2025
Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.
Journal: EJHaem
Published: December 07, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
Journal: Science translational medicine
Published: October 09, 2024
Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.
Journal: Blood
Published: August 26, 2024
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.
Journal: British journal of haematology
Published: April 19, 2024
Last Updated: 09/26/2026